Breaking Down Silos. Connecting Expertise. Accelerating Patient Impact.
Formerly known as Biomarkers, CDx & Precision Medicine US
Two days that move your precision medicine decisions forward.
At Precision Medicine West you hear the latest science across four programs, meet the R&D leaders, clinicians, data scientists, investors and technology providers working on the same problems, and leave with choices tested and partners found.
What you get from two days in San Diego
- Better decisions, sooner: pressure-test biomarker, CDx, data and AI choices before you commit budget.
- The missing link: the partner, capability or expertise you need, across the table.
- Less risk on what's coming: regulation, diagnostic strategy and AI adoption, from teams already working through them.
- A real benchmark: senior peers from pharma, biotech, academia and healthcare.
- More from one trip: four programs in place of several specialist meetings
Key Event Highlights
An unmissable journey awaits you: from celebrated keynote speakers and insightful private roundtables, to an exclusive gala dinner. Discover the moments that will transform your NextGen Omics & Spatial experience.
Explore dynamic panels, engaging roundtables, and hands-on workshops designed to drive innovation and foster collaboration, including:
Panel Discussion: Overcoming Multi-Omics Data Harmonisation & Analysis Challenges
Moderator: RUSLAN SADREYEV, Director of Bioinformatics & Assistant Professor, Massachusetts General Hospital
Panellists:
ARIDAMAN PANDIT, Senior Principal Research Scientist, AbbVie
FELIX FRANCIS, Sr. Manager, Data Management and Analytics Technology Lead, Takeda
LUCA PINELLO, Associate Professor of Pathology, Harvard Medical School
MEDHI DAMAGHI, Assistant Professor & Group Leader, Stony Brook University
SIMONA CRISTEA, Head of Genomics Data Science & AI, Dana-Farber Cancer Institute
LUCAS SCHÜTZ, Chief Operational Officer, AriadneAI
Presentation: Comparative Insights In Single Cell RNA-seq & Advances In Large-Scale Multimodal Profiling
ZORA MODRUSAN, Senior Director of NGS, Genentech
Panel Discussion: Guiding Immuno-Oncology Breakthroughs With Spatial Biology
Moderator: ALINA AINBINDER, Scientific Associate Director, Oncology, Takeda
Panellists:
JASMINE PLUMMER, Director, St. Jude Children’s Research Hospital
JIA-REN LIN, Technical Director of Tissue Imaging Platform, Harvard Medical School
NIR BEN CHETRIT, Assistant Professor, Weill Cornell Medicine
COLLES PRICE, Scientific Associate Director, Takeda
YASSER RIAZALHOSSEINI, Associate Professor & Head of Cancer Genomics, McGill University
Breakfast Roundtables - with topics including
• The Potential Of Multi-Omics In Cell & Gene Therapies
• New Frontiers In Liquid Biopsies
• Integrating Single Cell Data Across Samples
• Overcoming Cell Segmentation Challenges In Multiplex Immunofluorescence Biomarker Imaging
• Single Cell Multi- Omics Integration– From The Pharma Perspective
• Safety Biomarkers In The Age Of Spatial Biology
• Harnessing Spatial Transcriptomics In Immunoscience
• Spatial Analysis Of Cancer Data
• Advancing Spatial Biology Using The Complexities Of Immune Cell Interactions In
Explore dynamic panels, engaging roundtables, and hands-on workshops designed to drive innovation and foster collaboration, including:
Panel Discussion: What Is The Next Game Changer In Antibody Engineering?
Moderator: Karen Silence, Head Preclinical Product Development, ArgenX
Panellists include Berit Olsen Krogh, Senior Research Fellow; and Lundbeck Andrew Buchanan, Principal Scientist, AstraZeneca
Roundtable: Regulatory Insights On Bringing A Peptide To Human Trials
Moderator: Paul Reid, Co-Founder & Chief Scientific Officer, Celtic Bio
Workshop: Development Of Targeted Delivery Systems
Two Presentations, followed by a Panel Discussion on 'The Next Chapter Of Oligonucleotide Delivery'
Moderator: Steve Hood, Senior Director, Oligonucleotide ADME Strategy, GSK
Panel Discussion: Navigating The Paradigm Shift Towards Greener Approaches
Moderator: Walter Cabri, Full Professor of Organic Chemistry, University of Bologna
Panellists include Daniel Sejer Pedersen, Chemical Development Specialist CMC API Development, Novo Nordisk;
Anna Maria Papini, Full Professor & Group Leader, University of Florence;
Louis Diorazio, Senior Principal Scientist, New Modalities, AstraZeneca;
Alessandra Tolomelli, Associate Professor, University of Bologna
Presentation: How The RNA Technologies Could Help To Prevent Infectious Diseases And Could Be Applied To Various Chronic Disease Immunotherapies?
Presented by: Daniel Larocque, Innovation Lead, Innovation and Emerging Science, Sanofi
Who is Speaking at NextGen Biomed 2025?
Interested in Sponsoring NextGen Biomed?
Become a driving force in accelerating the next generation of biologics and immunotherapy medicines to patients. NextGen Biomed offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, and R&D experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, and collaborate with the community shaping the future of biomedicine today.
Interested in Sponsoring NextGen Biomed?
Become a driving force in accelerating the next generation of biologics and immunotherapy medicines to patients. NextGen Biomed offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, and R&D experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, and collaborate with the community shaping the future of biomedicine today.
Our Esteemed Sponsors for NextGen Biomed 2025
Gold Sponsors
Silver Sponsors
Bronze Sponsors
Network & Programme Sponsors
Start-Ups
The 1-2-1s are the best thing about Oxford Global events, well organised and good number of relevant contacts. Good high level contacts from big companies.
Advanced Therapies Specialist Team Leader,
Genscript
Biologics 2024 has been one of the best events I have attended so far in my career.
Territorial Sales Manager UK,
ACROBiosystems Co., Ltd.
Impressed by the effort to bring people together.
Business Development Director,
Bioassay
Nice set-up, with good support for exhibitors
Director of Client Relations,
ImmunoPrecise
The start-up zone provides a unique opportunity for you to exhibit, network, and pitch to our global audience of pharma, biotech, and investment professionals.
It's designed for start-ups from across the biologics space, working on cutting-edge therapies, innovative platform technologies, products, and solutions and is an ideal platform to share your business plans and promote your science.
There are two options, based on the type of your organisation with prices starting from £1,500 (+VAT) for companies with own therapeutic research pipeline and registration from £3,500 (+VAT) available for companies offering solutions, services or platform technologies.
For further information and to get started submit the application form below.
Criteria:
To qualify your company must be:
- Therapeutic Start-Up, Emerging Technology OR Service Start-Up
- Operating No More Than 5 Years
- 0 – 30 employees
- Pre-Series A Funding
Successful applications receive:
- 1 Full Conference Pass
- 10-Minute Presentation Opportunity
- 1x1m Space in Start-Up Zone
- Logo Featured on Event Website & App as a Participating Start-Up
- Ability to Arrange Peer to Peer Meetings via the Congress App
The NextGen Biomed Best Poster Presentation Competition & Award includes the best poster presentation award and is intended to honour an outstanding individual performance for a scientific work by either an early career or established scientist, including PhD student and PostDocs.
Please submit your poster presentation by no later than 13th January 2025 in the below category:
- Protein/Antibody Engineering
- Bioanalysis & Characterisation
- Next Generation Biotherapeutics
- Peptides Chemistry & Therapeutics
- Oligonucleotides Chemistry & Therapeutics
- Sustainable Chemistry & Manufacturing
-
- Open to all scientists, including students (PhD), PostDocs, and established researchers representing pharma & biotech companies and/or academic institutions
- Applicants must be the first AND presenting author of the submitted paper and register for the meeting by 13th January 2025
- ONLY ONE submission per person will be accepted. If authors submit multiple abstracts for consideration for the competition, only one abstract will be taken into consideration
Applicants must follow the procedure as follows:
- Register and submit an abstract by 13th January 2025 using the registration link to the right on this page. Please ensure you add the poster display option on the registration page to secure your admission into the Best Poster Competition & Award
- Once registered you will be provided with the online abstract submission form
- Prepare the poster or platform and present it (The poster presenter should be at the poster during all breaks.)
- The winner with the highest scores will be announced at the Morning Networking Break on Day 3 of the event
The poster presentations will be evaluated by everyone attending the event on the basis of originality of the approach and quality of the work (e.g. appropriate methodology, interpretation of results, conclusiveness). Attendees will be allowed to cast one vote by selecting their favourite work in the poster area. All votes will be counted at the end of Day 2 at 5pm and results will be announced during the morning networking break on Day 3. .
The winner receiving the highest scores will be announced on Day 3 and will be given a trophy as well as £600 contribution towards travel & accommodation costs to attend the 2026 NextGen Biomed event. Oxford Global will also provide winners with PLUS Pass – 12 months access to our digital content platform providing access to on-demand presentations, exclusive reports and highlights.
Who you'll meet
R&D leaders
Clinicians
Researchers
Data scientists
Investors
Technology providers
Formats built for exchange
Keynotes and cross-program panels: the big questions, across all four programs.
Collaboration Hubs: small-group sessions to test ideas and challenge assumptions.
Closed-door panels and roundtables: frank discussion among senior peers.
VIP program: Exclusive access to Collaboration Hubs, closed-door panel discussions, early Hackathon access and our steering group and advisory board, open to Director-level and above at pharma companies and Professors in academia.

Meet the people who matter
For delegates
The Partnering Program helps you find the right technology and service partners without spending your event walking the exhibition floor. Solution providers can see what you’re working on and the challenges you’re trying to solve, and they request a meeting when they have something relevant to offer. Each meeting is a focused 20-minute conversation in the Networking Lounge during the networking breaks, so it never takes you away from the sessions.
How you take part
When you register, tell us about your current projects and research challenges. The more detail you share, the more relevant your meeting requests will be. Before the event, we’ll let you know who would like to meet you, and when.
For solution providers
Six weeks before the event, you get access to the full registrant list.
Choose the delegates you want to meet, and we’ll arrange the meetings.
Come as a team
Precision medicine decisions cross biomarkers, pathology, omics and data. No single person can cover all four programs.
Come as a team, split the sessions and partnering meetings between you, and bring back a joined-up view of the whole field.
What attendees say
“Events like this help us understand more of the ecosystem, see the synergies and work out how to break down barriers, so that ultimately we can come together as a whole, as industry and academia, to build the best solutions out there for patients.”
Razik Yousif,
CEO & CTO, Paige
“None of these technologies are siloed from what we’re trying to achieve, and having them all under one umbrella, in one meeting, helps me decide where I want to be.”
Lauri Diehl,
Executive director, research pathology, Gilead
“The interactive sessions bring a multidisciplinary approach to the problems we’re trying to solve, letting the audience hear how people are overcoming hurdles, where the opportunities are, and how we as a community can work together to solve them.”
Robert Getzenberg,
US Medical Head Gastric Cancer, Astellas Pharma
“I have to highlight the interactions with a broader market of companies that are bringing new technologies to the marketplace, particularly in the translational medicine arena around digital pathology.”
Javier, Perez,
Senior director, Precision medicine, Regeneron
Frequently Asked Questions
Who should attend Precision Medicine West?
R&D leaders, clinicians, researchers, data scientists, investors and technology providers working across biomarkers, diagnostics, pathology, multi-omics, and AI and data.
Can I book one-on-one meetings at Precision Medicine West?
Can I attend more than one program at Precision Medicine West?
Can I bring my team to Precision Medicine West?
Yes. Precision Medicine West is free for qualifying delegates, so each member of your team registers individually at no cost. Coming as a team lets you split the four programs and partnering meetings between you. Solution providers and vendors attend on a paid pass or as partners.

.png)
